Navigation Links
Prostate Cancer Outcomes Determined By Socioeconomic Status

More than the available treatment methods, it is the socioeconomic status of an individual that determines the prognosis of prostate cancer, according// to a new study published in the March 15, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

The study found that education, community poverty, and income level played an equally important role in determining the outcomes as did age, disease stage, and treatment method. Prostate cancer is generally a slow growing malignancy and usually has very good prognosis, but it has shown racial predilection as far as mortality rate is concerned, affecting African-Americans more than Caucasians. In the current study, Xianglin L. Du, Ph.D., of the University of Texas School of Public Health at Houston, and colleagues reviewed the case histories of 61,228 men aged 65 years or older who were diagnosed over a period of 11 years. The reserachers found that the level of education, level of poverty in the community, and income played a significant role in the survival rate. The report also
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread

Post Your Comments:
(Date:11/27/2009)... SAN FRANCISCO, Nov. 27 ...d that Blair Lambert, CFO/COO, will present at the...eld at the May Fair Hotel in London, England, on W..., To listen to a live broadcast of The Gymboree C...e log on to www.gymboree.com, click on "Our Compan...
(Date:11/27/2009)...d cycling plus low-emission vehicles may reduce fu... FRIDAY, Nov. 27 (HealthDay News) -- Encouraging c...cars would offer much greater public health benefi....K. researchers have found. , The study compare...ive urban land transport scenarios for London, Eng...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
(Date:11/26/2009)...er sequestering drug tetrathiomolybdate (TM) has b...ent of Wilson disease, a disease caused by an over...at much is known. Very little, however, is known a... A new study led by Northwestern University resea...ree-dimensional structure of TM bound to copper-lo...
(Date:11/26/2009)... Research Triangle Dental (RTDental...h Carolina, today announced the expansion of its s...ER Dentist, Dr. Doug Macmillan. , ...e Dental is pleased to announce that Dr. Doug Macm...y completed an additional advanced training semina...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ssistance in the hardest hit ...0 More than 78,000 are dead and,millions are home...alteser,International has been providing assistanc... was among the few agencies able,to provide immedi...
...m Treatment of Chronic,Idiopathic Thrombocytopenic...(NYSE: GSK ),today announced that the United Stat...dvisory Committee (ODAC) unanimously voted, 16-0, ...ytopenic purpura (ITP). The FDA advisory committee...
...erienced a 50 percent membership ... MDwise employees today are,celebrating the latest...diana managed health care plan -- surpassing the 3...t -- going from just,over 50 employees at that tim...
...Nutrition has announced the 2008 American Gastroen...Scholars. The grants have been awarded to seven ou... make significant strides in the field of gastroin... a three-year period. The goal of the Research Sch...
...n can do to,our skin -- but what about the sun,s i...t from Transitions Optical at:, http://media.media...nalists can access video, audio, text, graphics an...ricted use at http://www.mediaseed.tv ., 05NY08...
...199C of the National Union of Hospital and Healthc... ratified a four-year contract agreement with,Hahn...rcent increase in,wages and benefits., District 1...negotiations begun Wednesday morning and concluded...
Other Medicine News:Health News:More Than 78,000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 3Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 4Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 2Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 3Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 4
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 American Scientific Re...s pleased to announce that they have opened a regi... Shanghai, China. ,, ASR has been able to secur...y for the development and production of current an...nd adults to be distributed and sold globally. Cu...
(Date:11/25/2009)... ERT (Nasdaq: ERES ), a...ompany,s President and CEO, and Keith Schneck, the...cheduled to present at the 21st Annual Piper Jaffr...er 1, 2009 in New York City, New York. ,, Inter...ing the Company,s corporate website at http://www...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 1ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 3SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2Shared Bed May Raise SIDS Risk 59436 1Shared Bed May Raise SIDS Risk 59436 2
...epatitis C and LymphoStat-B(R) for lupus on track ... -,- ABthrax(TM) for inhalation anthrax on track t...hened with investments in oncology portfolio and n... - GSK to advance darapladib to Phase 3 for ath...ome Sciences,Inc. (Nasdaq: HGSI ) today will repo...
... on Updated Results Showing a 20% Reduction in the...t of Disease Free Survival at Five Years, ...EWATER, N.J., May 28 Sanofi-aventis U.S.,announce... (FDA) approved,the supplemental new drug applicat...alysis from the MOSAIC trial in the Eloxatin(R) (o...
Other Medicine Technology:Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: